• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGilead

Gilead

Page 2 of 4
COVID forgotten communities
Newsletters
The communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
Health
Gilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
Gilead says COVID-19 recovery drug hit primary target
Health
Gilead says COVID-19 recovery drug hit primary target
By BloombergApril 29, 2020
Gilead coronavirus drug effective in coronavirus patients: report
Health
Gilead stock surges on report of coronavirus drug patients ‘seeing rapid recoveries’
By Drew Armstrong and BloombergApril 16, 2020
Gilead coronavirus
Newsletters
Gilead made a remarkable request of the FDA in regard to its coronavirus drug
By Sy MukherjeeMarch 25, 2020
Coronavirus drug Gilead Washington
Health
Gilead’s coronavirus treatment is already being used in Washington state
By Sy MukherjeeMarch 10, 2020
Gilead coronavirus trial
Newsletters
Can Gilead tame the coronavirus?
By Sy MukherjeeFebruary 27, 2020
Gilead remdesivir clinical trials
Health
Gilead’s coronavirus treatment is barreling its way into new clinical trials
By Sy MukherjeeFebruary 26, 2020
COVID-19-Coronavirus-microscope
Health
The first U.S. trial for a coronavirus treatment has started
By Sy MukherjeeFebruary 25, 2020
Coronavirus vaccine development
Health
The first coronavirus drug candidate is set for testing in China
By Sy MukherjeeFebruary 3, 2020
Biotech IPO Allogene
Health
Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By Sy MukherjeeOctober 11, 2018
The American Enterprise Institute photo of Scott Gottlieb
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By Sy MukherjeeMay 17, 2018
Hepatitis C drug can cure, if patients can get it
Health
Hepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300
By Sy MukherjeeApril 12, 2018
A picture taken on May 11, 2012 in a pha
Health
New Zealand Is About to Make the Revolutionary HIV Prevention Drug Truvada Almost Free
By Sy MukherjeeFebruary 7, 2018
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health
Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By Sy MukherjeeJanuary 22, 2018
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Economy
Economists have found an answer to slowing cognitive decline: Avoid retiring early, study findsplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.